Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. Markets closed

S&P 500
5,864.67
+23.20(+0.40%)
Dow 30
43,275.91
+36.86(+0.09%)
Nasdaq
18,489.55
+115.94(+0.63%)
Russell 2000
2,276.09
-4.76(-0.21%)
Crude Oil
69.34
-1.33(-1.88%)
Gold
2,736.40
+28.90(+1.07%)

Lexicon Pharmaceuticals Inc (LX31.BE)

Berlin - Berlin Delayed Price. Currency in EUR

Follow

1.9190

+0.0580

(+3.12%)

At close: 09:52PM CEST

Previous Close	1.8610
Open	1.8560
Bid	1.8370 x N/A
Ask	1.9830 x N/A
Day's Range	1.8480 - 1.9750
52 Week Range	0.8800 - 3.7000
Volume	1,000
Avg. Volume	395

Market Cap	N/A
Beta (5Y Monthly)	N/A
PE Ratio (TTM)	N/A
EPS (TTM)	N/A
Earnings Date	Nov 06, 2024 - Nov 11, 2024
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	N/A

All

BioPharma Dive
Lexicon sells Viatris rights to cardio drug outside of the U.S. and Europe
The deal offers Lexicon a cash infusion of $25 million as the company tries to broaden use of the heart failure and diabetes medication.
Pharmaceutical Technology
Lexicon partners Viatris for global expansion of sotagliflozin
Viatris will make an upfront payment of $25m to Lexicon.